424 OPTIMIZED HBsAg TITER MONITORING IMPROVES INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA von Ouzan, D, Pénaranda, G, Joly, H, Khiri, H, Halfon, P

Volltext

Prevalence and Characterization of NS5A Resistance Associated Variants in Patients who Relapsed following Exposure to NS5A Inhibitors von Halfon, P, Scholtès, C, Mohamed, S, Penaranda, G, Leroy, V, Bourlière, M, Ouzan, D, Polverel, L, Thélu, M.-A, Zoulim, F, Khiri, H, Larrat, S

Volltext

142 DRIED BLOOD SPOT FOR HEPATITIS B VIRUS SEROLOGY AND MOLECULAR TESTING von Halfon, P, Raimondo, A, Ouzan, D, Bourlière, M, Khiri, H, Cohen-Bacrie, S, Pénaranda, G, Ravet, S, Dukan, P

Volltext

824 IMPACT OF IL28B GENOTYPE ON HCV TREATMENT DECISION IN A LARGE FRENCH COHORT von Renou, C, Allègre, T, Ouzan, D, Bourlière, M, Delasalle, P, Lafeuillade, A, Cadranel, J.-F, Haddad, N, Asselah, T, Pénaranda, G, Sauser-Chirat, F, Khiri, H, Halfon, P

Volltext

Hepatitis C Virus Genotyping Based on 5′ Noncoding Sequence Analysis (Trugene) von HALFON, P, TRIMOULET, P, OUZAN, D, BOURLIERE, M, KHIRI, H, DE LEDINGHEN, V, COUZIGOU, P, FERYN, J. M, ALCARAZ, P, RENOU, C, FLEURY, H. J. A

Volltext

Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status von Halfon, P., Bourlière, M., Pol, S., Benhamou, Y., Ouzan, D., Rotily, M., Khiri, H., Renou, C., Pénaranda, G., Saadoun, D., Thibault, V., Serpaggi, J., Varastet, M., Tainturier, M.-H., Poynard, T., Cacoub, P.

Volltext

Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users von Bourlière, M., Barberin, J. M., Rotily, M., Guagliardo, V., Portal, I., Lecomte, L., Benali, S., Boustière, C., Perrier, H., Jullien, M., Lambot, G., Loyer, R., LeBars, O., Daniel, R., Khiri, H., Halfon, P.

Volltext

632 MONITORING VIROLOGIC ON TREATMENT RESPONSE TO PREDICT TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: REALTIME PCR ASSAYS AND BDNA/TMA PROVIDE THE SAME PERFORMANCES von Martinot-Peignoux, M, Khiri, H, Leclere, L, Marcellin, P, Halfon, P

Volltext

Evaluation of the VERSANT HCV RNA 3.0 Assay for Quantification of Hepatitis C Virus RNA in Serum von TRIMOULET, Pascale, HALFON, Philippe, POHIER, Eric, KHIRI, Hacène, CHENE, Geneviève, FLEURY, Hervé

Volltext

Slow viral dynamics of hepatitis C virus genotype 4 von Halfon, P., Neumann, A. U., Bourlière, M., Rieu, A., Chadapaud, S., Khiri, H., Ouzan, D., Cacoub, P.

Volltext

THU-237 - Prevalence and Characterization of NS5A Resistance Associated Variants in Patients who Relapsed following Exposure to NS5A Inhibitors von Halfon, P., Scholtès, C., Mohamed, S., Penaranda, G., Leroy, V., Bourlière, M., Ouzan, D., Polverel, L., Thélu, M.-A., Zoulim, F., Khiri, H., Larrat, S.

Volltext

Chronic Chlamydia pneumoniae infection in patients with symptomatic atherothrombosis von Halfon, P., Limal, N., Penaranda, G., Khiri, H., Sene, D., Andreu, M., Feryn, J.M., Rotily, M., Serra, R., Piette, J.C., Cacoub, P.

Volltext

Assessment of Spontaneous Fluctuations of Viral Load in Untreated Patients with Chronic Hepatitis C by Two Standardized Quantitation Methods: Branched DNA and Amplicor Monitor von HALFON, P, BOURLIERE, M, GEROLAMI, V, CARTOUZOU, G, HALIMI, G, KHIRI, H, BERTEZENE, P, PORTAL, I, BOTTA-FRIDLUND, D, GAUTHIER, A. P, JULLIEN, M, FERYN, J. M

Volltext

Impact of immune interventions on proviral HIV‐1 DNA decay in patients receiving highly active antiretroviral therapy von Lafeuillade, A, Poggi, C, Chadapaud, S, Hittinger, G, Khiri, H, Halfon, P

Volltext

Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C von Martinot-Peignoux, Michelle, Khiri, Hacène, Leclere, Laurence, Maylin, Sarah, Marcellin, Patrick, Halfon, Philippe

Volltext

Hepatitis B virus genotypes and extrahepatic manifestations von Cacoub, Patrice, Saadoun, David, Bourlière, Marc, Khiri, Hacene, Martineau, Agnes, Benhamou, Yves, Varastet, Marina, Pol, Stanislas, Thibault, Vincent, Rotily, Michel, Halfon, Philippe

Volltext

Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection von Cacoub, P., Bourlière, M., Hausfater, P., Charlotte, F., Khiri, H., Toci, S., Piette, J. C., Poynard, T., Halfon, P.

Volltext

Serological response to infection with different isolates of hepatitis C virus von Halfon, P., Bourlière, M., Khiri, H., Halimi, G., Gerolami, V., Feryn, J. M., Ouzan, D.

Volltext

Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma von Cacoub, P., Rosenthal, E., Gerolami, V., Hausfater, P., Ghillani, P., Sterkers, Y., Thibault, V., Khiri, H., Piette, J.C., Halfon, P.

Volltext

Quantitative multistandard RT-PCR assay using interspecies polymorphism von Khiri, Hacène, Reynier, Pascal, Peyrol, Nicole, Lerique, Brice, Torresani, Janine, Planells, Richard

Volltext